Showing results (101-110 of 349) with videos related to

Sort By:
Pageof 35
Brain Research|August 12, 2008
Ethanol-induced alterations of c-Fos immunoreactivity in specific limbic brain regions following ethanol discrimination trainingJoyce Besheer, Jason P Schroeder, Rebekah A Stevenson, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1994
Effects of intraaccumbens injections of dopamine agonists and antagonists on sucrose and sucrose-ethanol reinforced respondingC W Hodge, H H Samson, G A Tolliver, et al.
Alcoholism, Clinical and Experimental Research|August 7, 2015
CaMKIIα-GluA1 Activity Underlies Vulnerability to Adolescent Binge Alcohol DrinkingAbigail E Agoglia, Sarah E Holstein, Grant Reid, et al.
Nature Reviews. Clinical Oncology|March 9, 2016
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?Michael B Bernstein, Sunil Krishnan, James W Hodge, et al.
Human Immunology|January 1, 1991
A novel DRB1 allele in DR2-positive American blacksJ T Demopulos, T W Hodge, V Wooten, et al.
Cancer Immunology, Immunotherapy : CII|December 19, 2025
The ATR inhibitor tuvusertib (M1774) sensitizes prostate carcinoma to natural killer cell-mediated cytotoxicity, which is further augmented by the IL-15 receptor superagonist N-803Cailyn A Lee, Jeffrey Schlom, James W Hodge, et al.
Annals of the New York Academy of Sciences|June 28, 1992
Alcohol self-administration: role of mesolimbic dopamineH H Samson, G A Tolliver, M Haraguchi, et al.
Brain Research Bulletin|January 1, 1993
Effect of dopamine agonists and antagonists on ethanol-reinforced behavior: the involvement of the nucleus accumbensH H Samson, C W Hodge, G A Tolliver, et al.
Oncotarget|December 7, 2017
Combination therapy with an OX40L fusion protein and a vaccine targeting the transcription factor twist inhibits metastasis in a murine model of breast cancerAnthony S Malamas, Scott A Hammond, Jeffrey Schlom, et al.
Human Gene Therapy|March 27, 1999
Induction of anti-tumor immunity elicited by tumor cells expressing a murine LFA-3 analog via a recombinant vaccinia virusM G Lorenz, J A Kantor, J Schlom, et al.
Pageof 35